Navigation Links
Better preparedness against Tamiflu-resistant influenza viruses
Date:12/9/2013

Swedish researchers in Ume and Uppsala have found that residues of the influenza drug Tamiflu in our environment can make the influenza virus in birds resistant. This can have serious consequences in the event of an influenza pandemic. With more than 14 million SEK from the Swedish Research Councils Formas and VR, the research team will now continue their studies with a focus on alternative antiviral drugs.

Influenza is a viral respiratory infection that spreads rapidly and cause widespread epidemics. A severe influenza pandemic is a major health problem and treatment with antiviral medications is a central part of the preparedness plan. Tamiflu is the most widely used drug.

Hanna Sderstrm, environmental chemist and researcher at Ume University and Josef Jrhult, infectious disease physician and researcher at Uppsala University, together with Bjrn Olsen, professor at Uppsala University and Shaman Muradrasoli, researchers at SLU, Uppsala, have with a multidisciplinary approach followed what happens if Tamiflu comes out in nature.

"Our results show that Tamiflu's active metabolite, secreted by human urine, is not removed in traditional wastewater treatment plants. We have been able to trace Tamiflu in river water in Japan during the flu season 2007/ 08 as well as in Europe during the influenza pandemic 2009. Japan is the country that uses most antiviral drugs in the world during seasonal flu," says Hanna Sderstrm.

Based on the fact that dabbling ducks are the natural host for influenza viruses and that they often swim near the treatment plants, the researchers have examined whether influenza viruses in ducks exposed to Tamiflu via their bath and drinking water develops resistance.

"When ducks swim in water with environmentally relevant concentrations their influenza virus develop resistance. If a resistant influenza virus is spread to humans and causes a pandemic, this is a serious threat to public health since it takes many months to produce vaccine. We are therefore referred to the use of antiviral drugs during a pandemics first wave," says Josef Jrhult.

Today, Relenza is the drug that constitutes the first hand option when Tamiflu has no effect. It is therefore very likely that Relenza, and new antiviral drugs that are not yet out on the Swedish market, will be used more if the Tamiflu resistance increase.

With the money that the research group will receive they want to be one step ahead and develop a national knowledge center on effects of antiviral drug in the environment and the risk of development of resistant viruses.

"It is particularly important to examine the risk of resistance development before the drug is used more extensively so that we can adjust the prescription and implementation of a sound preparedness planning for future pandemics," says Josef Jrhult.

Another part of the research focuses on better waste water treatment. Ozone treatment has proven to be an effective method for treating waste water containing Tamiflu and the researchers will investigate whether the method can work for other antiviral drugs as well.


'/>"/>

Contact: Hanna Söderström
hanna.soderstrom@chem.umu.se
46-702-200-994
Umea University
Source:Eurekalert  

Related biology news :

1. More logging, deforestation may better serve climate in some areas
2. Fruit flies with better sex lives live longer
3. New clues to memory formation may help better treat dementia
4. NREL test helps make moisture barriers better
5. 5 tips for a better Thanksgiving: A new video by the American Chemical Society
6. Antibiotic resistance is a international issue that better education can address
7. Better batteries through biology?
8. Cancer cant hide; better heart shocks; mechanical leeches
9. Single-cell genome sequencing gets better
10. Lawrence Livermore researchers unveil carbon nanotube jungles to better detect molecules
11. Crafting a better enzyme cocktail to turn plants into fuel faster
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Better preparedness against Tamiflu-resistant influenza viruses
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/15/2016)... , March 15, 2016 ... report published by Transparency Market Research "Digital Door Lock Systems ... Forecast 2015 - 2023," the global digital door lock systems ... Mn in 2014 and is forecast to grow at a ... of micro, small and medium enterprises (MSMEs) across the world ...
(Date:3/11/2016)... HANOVER, Germany , March 11, 2016 ... - Cross reference: Picture is available at AP Images ( ... scanner from DERMALOG will be used to produce the new refugee ... of other biometric innovations, at CeBIT in Hanover ... LF10 scanner from DERMALOG will be used to produce the new ...
Breaking Biology News(10 mins):
(Date:5/26/2016)... , ... May 26, 2016 , ... ... company, today announced several positive developments that position the Company for the future. ... of the transaction, Craig F. Kinghorn has been appointed Chairman of the Board, ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Ankle Plating ... options designed to address fractures of the distal tibia and fibula. This system ... Ankle Plating System 3 is composed of seven plate families that span the ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... WEDI, the ... information exchange, today announced that Charles W. Stellar has been named by the WEDI ... CEO since January 2016. As an executive leader with more than 35 years of ...
(Date:5/24/2016)... , May 24, 2016   MedyMatch Technology Ltd ... with artificial intelligence, real-time decision support tools in the emergency ... at the 2016 Israeli Advanced Technology Industries (IATI) BioMed Conference. ... Israel,s 15th National Life Sciences and Technology ... the David Intercontinental Hotel in Tel Aviv, Israel ...
Breaking Biology Technology: